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Approximately 53 million Americans live with a disability.
For decades, the National Institutes of Health (NIH) has
been conducting and supporting research to discover new
ways to minimize disability and enhance the quality of life
of people with disabilities. After the passage of the American
With Disabilities Act, the NIH established the National
Center for Medical Rehabilitation Research with the goal of
developing and implementing a rehabilitation research
agenda. Currently, a total of 17 institutes and centers at
NIH invest more than $500 million per year in rehabilitation
research. Recently, the director of NIH, Dr. Francis Collins,
appointed a Blue Ribbon Panel to evaluate the status of
rehabilitation research across institutes and centers. As a
follow-up to the work of that panel, NIH recently organized
a conference under the title “Rehabilitation Research at NIH:
Moving the Field Forward.” This report is a summary of the
discussions and proposals that will help guide rehabilitation
research at NIH in the near future.
The conference took place at the NIH Campus on May 25
and 26, 2016. It was cosponsored by The Eunice Kennedy
Shriver National Institute of Child Health and Human
Development, the National Institute of Biomedical Imaging
and Bioengineering, the National Institute of Neurological
Diseases and Stroke, the National Institute of Nursing
Research, the National Institute on Deafness and other
Communication Disorders, the National Center for
Complementary and Integrative Health, and the Office of
Disease Prevention. The main objectives of the Conference
were to (1) discuss the current NIH portfolio in rehabilitation
research, (2) highlight advances in rehabilitation research
supported by NIH, and (3) provide an opportunity for scien-
tists and the general public to comment on gaps in knowl-
edge, opportunities for training, and infrastructure needs. The
program included a total of 13 expert panels, four remarks by
NIH leaders, a consumer keynote, a town hall, a poster ses-
sion, and the use of social media to disseminate information
in real time. The following is a summary of the discussion and
the subheadings correspond to the title of the expert panels.
Rehabilitation across the lifespan
(Moderator: Alan Jette, PhD, Boston University; Panelists:
Andrea Cheville, MD, Mayo Clinic; Jonathan Bean, MD,
Boston University; Shari Wade, PhD, Cincinnati Children’s
Hospital Medical Center)
The theme of this session was moving rehabilitation inter-
ventions from a traditional “one-and-done” isolated model of
care to one where rehabilitation interventions are integrated
into the mainstream of health care. The speakers addressed
integrated care approaches in cancer care, primary care, and
pediatric rehabilitation.
Barriers to integrating function-directed care into the com-
prehensive management of progressive diseases, particularly
those with a heavy treatment burden, were identified. Cancer
was used an exemplar of the simultaneously dynamic and
insidious nature of disablement in chronic illness.
Collaborative care approaches, including telecare, validated
for pain and depression management, was considered a
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promising means to proactively and patient-centrically
address cancer-related disablement. Current research in can-
cer rehabilitation suggests that challenges revolve around
issues such as patient selection and timing, when and how
to intervene, limitations of linear impairment-to-disability
models (with multiple mild impairments the norm), and
competition with disease-modifying therapies. Although func-
tional limitations are prevalent (seen in 65% of all cancer
patients), rehabilitation intervention remains underused. In
contrast to ischemic and traumatic injuries, rehabilitation
interventions in patients with cancer are less prescriptive,
more negotiable, and subject to patient preferences. Current
care delivery overwhelmingly emphasizes primary disease
management.
Another presentation focused on limitations with mobility
tasks, such as walking, rising from a chair, or climbing stairs,
as a signal condition identifying older adult primary care
patients at an increased risk for disability, morbidity, and
death. It was discussed how rehabilitative care can play a
critical role with older adult primary care patients by devel-
oping integrated care paradigms between primary and reha-
bilitative care providers focused on prevention of mobility
decline among older adults. Prevention of adverse health out-
comes represents a new conceptual role for rehabilitative care.
Research priorities include determining the optimal content
and design of preventative rehabilitative care; the potential
benefits for patients, families, and health care organizations;
and the cost/benefit of such approaches to care.
Traumatic brain injury (TBI) was used as a case example to
discuss the need for further research on ways to integrate
pediatric rehabilitation into the broader framework of child
development. TBI is currently viewed as a discrete event with
time-limited consequences while evidence from the TBI
Model Systems suggests lifelong physical and cognitive con-
sequences. Long-term pediatric studies are lacking, but exist-
ing evidence suggests long-term effects on educational
attainment and vocational and social success. However, after
the post–acute recovery phase, children with TBI receive little
ongoing rehabilitation. TBI-related problems that emerge
with shifting developmental demands may go unrecognized
or be inaccurately characterized. Families and schools consti-
tute powerful contexts for ongoing rehabilitation and later
habilitation. How families function and interact with the
child exerts a powerful influence on the recovery trajectory.
Interventions need to be developmentally tailored and address
the current developmental and neural context. Challenges
remain in framing rehabilitation/habilitation as an ongoing
process with tune-ups at various developmental stages rather
than a one and done model. A better understanding of adult
outcome metrics (e.g., education and employment) and long-
term burden (disability and life quality) is needed. To reduce
heterogeneity and improve prediction, research is needed to
better categorize the initial injury/insult along with better
understanding of effects on neurodevelopment and how this
relates to long-term functional outcomes. Multicenter consor-
tiums are urgently needed to support larger-scale outcome
studies and provide an infrastructure to link school and med-
ical data as well as study interventions and management
practices more efficiently.
Technology in rehabilitation: From cutaneous to
implanted
(Moderator: Ranu Jung, PhD, Florida International
University; Panelists: Leigh Hochberg, MD, PhD, Harvard
University; Reggie Edgerton, PhD, University of California,
Los Angeles; Joseph Rizzo, MD, Harvard University; Mario
Svirsky, PhD, New York University)
Innovation and advances in engineering and computing
are having a ubiquitous impact on health and well-being.
The purpose of this panel was to discuss the challenges and
opportunities for developing technologies that interface with
the nervous system at an appropriate level, are user-centric
and responsive to the ability of the user and their life-span,
and could provide new neuroscience insights to inform reha-
bilitation science. The panel also discussed the importance of
having appropriate assessment methodologies and compre-
hensive engagement with regulatory, industry, and clinical
partners. The moderator and panelists brought to the discus-
sion their experience as neuroscientists, biomedical engineers,
and clinical practitioner, some with personal experience of
moving neurotechnology from the laboratory to human stu-
dies. Using examples from engineering of cochlear and visual
prosthetic devices, brain, spinal cord, and peripheral nerve
interfaces, they discussed the role of technology in scientific
discovery and recovery and restoration of missing or lost
function.
The overall span of the technology that can influence
rehabilitation is broad: from assistive devices, rehabilitation
robotics and implanted neuroprostheses to augmented con-
nectivity between people and devices, use of virtual reality
environments for training, and use of mobile health and
telehealth platforms for deployment of rehabilitative thera-
pies. The panel discussions focused on implanted neuro-
prostheses. Advances in neurotechnology will allow us to
better access information about the living system at multiple
scales, from cellular to behavioral. Improved understanding of
the endogenous activity patterns of neural activity could help
guide the design of neuroprostheses that can more precisely
influence and modify the neural activity to initiate and sustain
long-term beneficial neuroplasticity leading to repair or
recovery. Design, development, and deployment of the neu-
roprostheses that form biohybrid systems with the living body
has many challenges.
A major challenge in the deployment of neuroprostheses
that effect recovery is to make the neuroprostheses adaptive
and patient-centric. The panel discussed that the scheduling
(timing) for introducing rehabilitation technology after a
traumatic event to patients is very important. In addition,
whether all of the capabilities for the neurotechnology should
be introduced immediately or in a controlled sequential man-
ner after deployment has to be considered. For example, after
a bilateral sequential implantation of cochlear implants,
should they be deployed sequentially or together? To restore
function after incomplete spinal cord injury (SCI), should
epidural stimulation be conducted in parallel with or before
treadmill training? Recovery of function is very patient spe-
cific and may confound assessment of the effectiveness of
different neural stimulation paradigm interventions. To
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design appropriate rehabilitation therapies, conduction of
scientific studies in tandem with technology development
would be highly beneficial. This in itself raises new challenges.
Several of the technological interventions could require
extensive development, and the underlying science of rehabi-
litation may be insufficient to support the use of these tech-
nologies for larger-scale human use. It is essential that early
development of neurotechnologies, including the scientific
studies that provide the evidence, are conducted with close
consultation of the regulatory bodies such as the Food and
Drug Administration. Safety and reliability small early-
feasibility-trials need to be considered. In this context, the
panel suggested that for sequential improvements in technol-
ogy, a modular design be used. In addition, giving the parti-
cipant at least some control over use of the technology as
needed was considered important. This requires the develop-
ment of a regulatory acceptance pathway. There was consid-
erable discussion on the design of study protocols with small
numbers of enrolled participants. Each participant’s own abil-
ities with turning on or shutting off the device could be used
as an internal control for device evaluation, thereby formaliz-
ing and extending the value of small studies. The lack of
commercial support for conducting small subject studies
with the associated legal and regulatory requirements indi-
cates that governmental funding support for technology
development and early-feasibility trials is paramount for
translation of the neurotechnologies from the laboratory to
the clinic.
A key outcome from the panel discussion was that
implanted neurotechnologies offer a “precision medicine”
approach to rehabilitation. They target specific neural popula-
tions. The stimulation paradigms could be combined with
other treatments, especially cell therapies, to maximize func-
tion. This ability for precision deployment could be further
tailored to take advantage of the genetic makeup of the reci-
pient to make it a personalized, adaptive approach to
rehabilitation.
Mechanisms and markers of activity and function
Exercise, Plasticity, and Mechanism: How is Rehabilitation
Happening?”
(Moderator: Keith Tansey, MD, PhD, Methodist
Rehabilitation Center; Panelists: Rick Lieber, PhD, Rehabilitation
Institute of Chicago; Stephen Seliger, MD, University of
Maryland; James Blumenthal, PhD, Duke University)
Rehabilitation interventions are applied to various patient
populations with diverse physiological profiles over extended
periods with relatively little evidence regarding how which
interventions are doing what in whom. Patients with neuro-
logical problems need to be characterized better so that we
can identify and analyze responders versus nonresponders.
Monitoring tools to ensure that rehabilitation interventions
are proceeding toward more normal physiology over time are
also needed. Neurological plasticity after injury can be both
adaptive and maladaptive and we need to work to gain the
former while limiting the latter. Similarly, skeletal muscle
plasticity is important in injury and rehabilitation, but classic
measures rarely capture the functionally relevant properties of
skeletal muscle. Most plasticity studies focus on muscle active
properties such as force generation and fatigue and less so on
problems involving passive mechanical properties due to con-
tracture or fibrosis. New areas of investigation in the field
include extracellular matrix structure and function and the
development of new imaging methods that would permit
mesoscale quantitative measures of muscle performance that
are objective and clinically relevant. Older adults with chronic
kidney disease have impaired neurocognitive function, physi-
cal performance, and aerobic capacity. Research has been
done on the mechanisms associating kidney disease to physi-
cal and cognitive impairment. Exercise training improves
neurocognitive function and protects against cognitive decline
in chronic renal disease patients. Finally, patients undergoing
cardiac rehabilitation benefit from stress management. The
Enhancing Cardiac Rehabilitation With Stress Management
Training trial shows the beneficial effects of combining stress
management training with standard exercise-based cardiac
rehabilitation in terms of stress levels, coronary heart disease
biomarkers, and clinical outcomes. These findings should be
disseminated and cardiac rehabilitation program including
stress management should be made more accessible to
patients with coronary heart disease.
The major issues identified and questions raised in this
session for further consideration going forward were as fol-
lows. We have to address diverse populations (physiologically)
in rehabilitation, even within a given diagnosis. We also need
to address our lack of mechanistic understanding of interven-
tions, in preclinical and clinical scenarios, which makes pre-
dicting responders versus nonresponders difficult and makes
translation from animal model to human problematic as well.
The idea of tracking progression during an intervention was
introduced: Are we generating more normal biology/function
or developing “work-arounds” in rehabilitation? The question
was raised as to whether we are measuring the right biological
markers in our systems, the ones that are actually critical to
the pathophysiology/impaired function, so as to develop
appropriate interventions. We may need to develop better
assessment tools (imaging for instance) to understand these
issues. We may also need to connect previously unconnected
areas of medicine (chronic disease states and their neurologi-
cal impact for instance) to make a wider impact with our
interventions. Finally, we should partner psychological inter-
ventions with rehabilitation interventions to have a greater
impact overall on human health.
Access to the lived environment
(Moderator: Melanie Fried-Oken, PhD, Oregon Health &
Science University; Panelists: Cole Galloway, PhD,
University of Delaware; Maureen Schmitter-Edgecombe,
PhD, Washington State University; James Coughlan, PhD,
Smith-Kettlewell Eye Research Institute)
This panel presented and discussed evidence that assistive
technologies (ATs) provide functional tools to ensure that
individuals experience their greatest level of functional inde-
pendence in daily life. Based on the International
Classification of Functioning, Disability, and Health of the
World Health Organization, AT is a facilitator for activities
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and participation for individuals who experience disability
and chronic health conditions. The technologies being devel-
oped, discussed, and tested by this panel are often mainstream
technologies available to the general public that are adapted to
meet functional needs and access to daily environments.
Devices, such as off-the-shelf toy racecars that can provide
mobility to children with physical impairments, environmen-
tal controls with infrared sensors to support or assess elders
with dementia who are aging in place, and application soft-
ware for touch tablets and mobile phones that guide travelers
with visual impairments at traffic intersections, were dis-
cussed and demonstrated through multimedia presentations.
The panel discussed three common themes and a number
of challenges to the design, testing, and implementation of
ATs, including the following:
(1) Participatory action research as a critical element of
rehabilitation research. Individuals with disabilities
must be included in all stages of hypothesis testing
and analysis to ensure content validity. Participatory
action research is sensitive to group as well as indi-
vidual differences (i.e., cultural, ethnic, lifestyle diver-
sity) and leads to people having increased control
over their lives.
(2) The utility of AT for value added to end-users and
professionals must become a priority for rehabilitation
science. Utility measures such as task performance (e.g.,
efficiency and effectiveness of task completion), user
satisfaction, and quality of life must become standard.
It is challenging to measure value because the user
population is extremely heterogeneous in terms of
needs, abilities, and preferences. Researchers must
determine if it is better to assess utility for a narrow
population who is most likely to benefit from AT or a
broad population, where only a subset of individuals is
likely to benefit. The variability of user population and
task conditions can make it very hard and/or costly to
get good statistics on utility. Although statistical success
is easier to obtain under controlled laboratory condi-
tions, the laboratory conditions do not translate to real-
world conditions. Measurement of user satisfaction (or
dissatisfaction) and quality of life, constructs that are
often used for outcomes, has challenges, as well.
(3) AT must be scaled, in terms of sustainability and
accessibility, to the population. As technology is
rapidly advancing, we must try to get at the back
end of it even as it gets more complex. For example,
as infrared sensors became wireless, laboratories and
smart homes needed to adjust so that our tools are
sustainable. For the biggest impact, one goal in tech-
nology research and development must include keep-
ing products and services affordable so they can be
accessed by the population who needs them.
Likewise, we must increase awareness and benefits
of ATs for the general public. The AT must meet
the environmental and personal demands of the end
users, while protecting privacy, maintaining confi-
dentiality and security of personal information.
Individuals, families, and community
(Moderator: Linda Ehrlich-Jones, PhD, Rehabilitation
Institute of Chicago; Panelists: Christopher Murtaugh, PhD,
Visiting Nurse Service of New York; George Alexopoulos,
MD, Cornell University; Sara Czaja, PhD, University of
Miami Miller School of Medicine)
Rehabilitation interventions incorporating the home, the
family, and the community promote active engagement of
patients, family, and community members to achieve increased
quality of life for people with disabilities. Psychosocial interven-
tions aimed at reducing post-stroke depression and stress rely on
five integrated components: (1) offer patients action-oriented
“new perspective” about recovery; (2) provide an “adherence
enhancement structure”; (3) offer a “problem solving structure”
to the patient focusing on problems, valued by the patient, and
pertinent to daily function; (4) help the patient’s family “reengi-
neer its goals, involvement, and plans” to accommodate the
patient’s disability; and (5) “coordinate care with specialized
therapists” with the goal to increase patient participation in
rehabilitation and social activities.
The outcomes of patients receiving physical therapy at home
for activity-limiting pain, total hip or knee replacements, and
implantable cardiac devices show some improvement over
time. Family caregivers play a critical role in supporting older
adults and family members with a chronic disease or disability.
Intervention strategies that are aimed at supporting family
caregivers and reducing caregiver burden with an emphasis
on technology-based interventions are needed to facilitate
improved outcomes in people with disabilities. The end goal
of incorporating the home, the family, and the community is
greater independence and providing opportunities for people
with disabilities to actively contribute to their community.
Strategies that help individuals to self-manage their disability
can lead to achievement or maintenance of positive outcomes.
The challenges experienced by caregivers of individuals with
disabilities need further attention.
Gaps and opportunities for future research include exam-
ination of the impact of sociodemographic influences, includ-
ing geography, socioeconomic status, education, and
language/culture on rehabilitation success. In addition, devel-
opment of self-management strategies that can be implemen-
ted in community settings to help individuals better
understand and manage their disability and achieve or main-
tain positive quality of life and independence are necessary
areas of future research.
Understanding the context: Environmental impacts
in rehabilitation
(Moderator: Michael Mueller, PhD, Washington University
School of Medicine; Panelists: James Burke, MD, University
of Michigan; Amanda Botticello, PhD, MPH, Kessler
Foundation; Patrick Kitzman, PhD, University of Kentucky)
The purpose of this session was to consider how environ-
mental factors impact outcomes in rehabilitation. The “envir-
onment” is an important, modifiable, and understudied
element in the International Classification of Functioning,
Disability and Health framework. An example was provided
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for patients with diabetes and peripheral neuropathy that
illustrated how a conceptual framework had been used to
help direct interventions at the environmental level (casting,
footwear, community screening, and education) to reduce the
rate of lower extremity amputation. Other, more complex
models are being developed to illustrate ways in which race
and socioeconomic factors may interact with contextual fac-
tors such as caregiver support, transportation, neighborhood
environment, and social network to limit access to rehabilita-
tion. Some drivers of racial differences in post-stroke disabil-
ity are modifiable and we should consider stroke survivor and
family level strategies to reduce disability and decrease
disparities.
There are links between community context and long-term
outcomes for persons with SCI. Community characteristics
such as socioeconomic disadvantage, resource deprivation,
segregation, and physical inaccessibility likely threaten the
physical, psychological, and social functioning gains achieved
during rehabilitation. Neighborhood socioeconomic factors
affect health and well-being over and above personal charac-
teristics. For example, employment rates for SCI are poor with
rural < suburban < urban. The best prospects for employment
and community participation are for those people with SCI
and high socioeconomic status in urban environments. The
challenge of providing rehabilitation services to people with
SCI in rural settings was highlighted with a description of a
specific program targeting rural Kentucky, a state at the
bottom of several US health outcome measures. The
Kentucky Appalachian Rural Rehabilitation Network is work-
ing to overcome these barriers and encourages a bidirectional
flow of information, providing clear benefits for the commu-
nity, being accountable and providing long-term commitment
(i.e., sustainability) to the community.
All presentations and discussion highlighted the fact that
interactions between environment and outcomes are highly
complex and vary according to location, socioeconomic
level, race, age, and disability. Understanding these complex
relationships will require further refinement of conceptual
models and a variety of research approaches to understand
outcomes and devise policy to enhance outcomes. The use
of “big data sets” is useful and the net of these data sets
need to be spread even further to capture common concerns
across wide geographical areas. Consistent with other ses-
sions, there is a need for common outcome measures but
also for qualitative studies to better understand these
themes at an individual level. Finally, another important
theme was the need for ongoing support for people with
chronic disabilities. Longitudinal research is needed to
determine how disability affects people in their environment
over time. Intervention should not be “one and done” but
should dynamically meet the ongoing and changing needs
of people with chronic health problems.
Effective pathways to evidence for rehabilitation
(Moderator: James Malec, PhD, Indiana University School of
Medicine/Rehabilitation Hospital of Indiana; Panelists: Lynn
Snyder-Mackler, PT, ScD, University of Delaware; Catherine
Lang, PhD, Washington University; Susan Horn, PhD,
University of Utah)
This symposium examined phases, options, and challenges
in advancing a line of rehabilitation research. Methodologies
for addressing challenges were explored as well as for incor-
porating mechanisms, defining dose, and examining the effec-
tiveness of standard rehabilitation procedures.
Traditional phases in a line of research include idea gen-
eration, natural history and/or animal models, early human
testing for safety and feasibility, efficacy trials, and effective-
ness trials. This sequence may be most informative if viewed
as iterative and recursive rather than linear. Designs such as
the randomized controlled trial (RCT) offer strong internal
validity. However, some aspects of the RCT, for example,
participant and researcher blinding and development of a
viable control condition, may be difficult to implement in
rehabilitation research. Other designs, such as, large-scale
observational or practice-based evidence trials, may offer
stronger external validity. Balancing internal and external
validity is critical to encourage timely translation into prac-
tice. Other considerations and challenges in advancing reha-
bilitation research include heterogeneity of participants and
interventions (which are typically individualized in practice),
fidelity assurance, dosing, consideration of nonspecific factors
as moderators as opposed to confounders of treatment effect,
and the precision of measurement tools used to assess out-
comes that are not directly observable and must be assessed
by observer or participant rating.
Investigating the underlying mechanisms of action in
high-quality clinical trials and observational quasi-
experimental studies within rehabilitation research is
achievable but fraught with obstacles that do not occur in
typical clinical drug trials. Unlike the delivery of an active
medication or placebo, rehabilitation interventions are typi-
cally multimodal and involve active participation of both
the patient and the clinicians. Thus, ensuring fidelity, that
is, defining the intervention(s), ensuring that the
intervention(s) are reliably applied and defining the active
component(s), is particularly challenging in studies of reha-
bilitation. Use of fidelity metrics, ideally completed by more
than one observer, addresses this challenge. In rehabilitation
research, outcomes are often complex, occur across the
domains of the International Classification of Function,
and include patient-reported as well as performance-based
and instrumented outcomes. Consequently, strategic selec-
tion and pretrial testing of precision outcome metrics and
control conditions are critical.
It is also critical to consider dosing in rehabilitation trials to
not waste resources and to eventually improve outcomes. In
rehabilitation, dose is an interaction of multiple parameters.
Explicit studies of dose-response are necessary to determine
essential information about active ingredients, their biological
targets and mechanisms of action, and their half-lives. As with
other elements of high-quality clinical trials, key dosing para-
meters are best determined through pretrial feasibility study.
Methods to determine appropriate dose include (1) careful
quantification of the active ingredient, (2) multiple assess-
ments over the course of the intervention, (3) multiple groups
receiving different doses, and (4) sophisticated statistical
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modeling of data across time (e.g., hierarchical linear model-
ing, individual growth curve analysis).
Electronic medical records are collecting detailed patient,
treatment, and outcome data now and will do so even more in
the future. This information can be used to determine those
interventions that are associated with better outcomes for
patients with specified sets of characteristics through practice-
based evidence study designs. Practice-based evidence is an
example of an innovative research methodology that
addresses many of the challenges to the traditional RCT
posed by rehabilitation research.
This symposium identified a number of challenges to
interventional rehabilitation research, including heterogeneity
of participants, individualized and complex treatments, balan-
cing internal and external validity, implementing viable con-
trol conditions, difficulty blinding participants and
researchers, nonspecific treatment moderators, fidelity assur-
ance, and dosing. A greater emphasis on pretrial studies and
alternative designs to the traditional RCT offer opportunities
to address many of these challenges.
Central and peripheral mechanisms of rehabilitation
(Moderator: Rick Lieber, PhD, Rehabilitation Institute of
Chicago; Panelists: D. Michele Basso, PhD, Ohio State
University; Monica Perez, PhD, University of Miami; Mike
Boninger, MD, University of Pittsburgh)
In this session, the mechanisms of plasticity in rehabilita-
tion were discussed. The presenters focused on approaches to
measuring brain, spinal cord, and skeletal muscle function
and discussed how rehabilitation and regenerative therapies
could be applied to improve central and peripheral function.
Human skeletal muscle adapts to contractures that occur
secondary to stroke and cerebral palsy (CP). Intraoperative
structural studies of upper extremity muscles show that sar-
comere length increased while serial sarcomere number
decreased dramatically. The extracellular matrix in contrac-
tures was deranged (hypertrophic and altered composition)
and apparently does not support a functional stem cell niche.
Using both flow-assisted cell sorting and immunohistochem-
istry, it has been demonstrated that satellite cell number
(muscle stem cells) is decreased by about 70% in contractures.
This may cause muscle shortening, deranged extracellular
matrix, and increased muscle stiffness. Finally, studies of
gene expression from these muscles revealed altered transcrip-
tional pathways relative to other models of decreased use such
as immobilization, SCI, or spaceflight. Thus, muscle contrac-
ture represents a dramatic and unique model that must be
understood mechanistically to develop novel treatment
approaches.
Studies at the cellular level may explain why SCI rehabili-
tation can be quite effective in some individuals while others
show limited improvement. In rodent models of contusion,
the timing to deliver task-specific training and cellular factors
that are conducive to motor learning has been determined.
These findings suggest that inflammation in cord regions
remote to the injury is a barrier to effective rehabilitation. In
fact, animal models show that training delivered early after
SCI during high inflammation worsens function but reducing
this inflammation allows robust locomotor recovery using a
brief training paradigm. The source and genetic profiles of
cellular inflammation have been identified, which may allow
development of biomarkers for rehabilitation.
New neuroplasticity protocols are being used in humans
with SCI, and noninvasive electrophysiology can be used to
guide therapeutic interventions. The corticospinal tract is an
important target for motor recovery after SCI. Noninvasive
techniques have been used to develop tailored protocols for
precise timing of the arrival of descending and peripheral
volleys at corticospinal synapses of upper and lower limb
muscles in humans with chronic partial paralysis. Voluntary
motor output depends on the efficacy of synapses between
corticospinal axons and spinal motor neurons, which can be
modulated by precise timing of central and peripheral neuro-
nal spikes. Thus, noninvasive techniques can be used to
develop tailored protocols for precise timing of the arrival of
descending and peripheral volleys at corticospinal-spinal
motor neuron synapses involved in intrinsic finger muscle
function in humans with chronic incomplete SCI. Using elec-
trophysiological measurements by stimulating different levels
of the corticospinal pathway in individual subjects, accurate
estimates of the time of arrival of action potentials to the
muscle have been measured; indeed, latencies of electromyo-
graphic responses relied on the generation of action potentials
in motor neurons. The results indicate that arrival of presy-
naptic volleys before motor neuron discharge enhances corti-
cospinal transmission and hand voluntary motor output. In
contrast, the reverse order of volley arrival and sham stimula-
tion does not decrease voluntary motor output and electro-
physiological outcomes. Overall, these findings demonstrate
that spike timing-dependent plasticity of residual corticosp-
inal-spinal motor neuron synapses provides a mechanism to
improve motor function after SCI. Modulation of residual
corticospinal-spinal motor neuron synapses may present a
novel therapeutic target for enhancing voluntary motor out-
put in motor disorders affecting the corticospinal tract.
The integration of principles and approaches in rehabilita-
tion science and regenerative medicine may help us develop
innovative and effective methods that promote the restoration
of function through tissue regeneration and repair. The appli-
cation of rehabilitation protocols in combination with cellular
therapeutics for the treatment of injured or diseased tissue
enhances transplantation efficacy and improves functional
outcomes. Although it is clear that the convergence of reha-
bilitation approaches with regenerative medicine strategies
will accelerate the science underlying tissue restoration after
injury and disease, collaborative research efforts across the
fields of regenerative medicine and rehabilitation are greatly
lacking. An NIH reporter search of active funding using the
Boolean terms “regenerative medicine” yielded over 2231
studies. When we modified this search to only include “phy-
sical medicine and rehabilitation” and “other health profes-
sions,” which include physical therapy, occupational therapy,
and speech language pathology departments, only a total of 16
grants were displayed. This is remarkable considering that the
promotion of tissue healing and regeneration is a primary
goal of many rehabilitation interventions. There is, therefore,
a great need to expand scientific knowledge, expertise, and
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methodologies across the domains of rehabilitation science
and regenerative medicine, with the ultimate goal of improv-
ing the lives of individuals with disabilities.
Gaps in the understanding of mechanisms underlying
rehabilitation include the following questions: (1) What has
the greatest impact on skeletal muscle strength, the nervous
system or the biomechanical manipulation of muscle? (2)
Which stem cell populations can rehabilitation professionals
realistically manipulate? (3) How can exercise influence the
stem cell population? (4) How do bio-scaffolds interact with
stem cells? (5) Because the timing of SCI treatment is an
important factor in good outcomes, how will we be able to
translate animal studies into human treatments? (6) What are
the most appropriate strategies for applying regenerative med-
icine to rehabilitation? (7) Does the cellular state of the CNS
dictate the response to rehabilitation treatment or can the
right type of exercise modify the cellular environment to
create permissive learning conditions?
Bending the arc of technology toward rehabilitation
and health
(Moderator: Aiko Thompson, PhD, Medical University of South
Carolina; Panelists: Steve Cramer, MD, University of California,
Irvine; James Rimmer, PhD, Lakeshore Foundation; Susan
Magasi, PhD, University of Illinois at Chicago)
The purpose of this session was to discuss how the inte-
gration of technology into rehabilitation, health care, and
wellness services can promote better communication between
health care professionals and patients and thereby achieve
healthy lifestyles and better quality of life.
The use of information and communication technologies
eliminates distance barriers and can make rehabilitation and
health care services available to people who have limited
access to transportation and other access issues. In recent
years, digital health (e.g., telehealth, telerehabilitation [telere-
hab], eHealth [health care services delivered or enhanced
through the Internet], and mHealth [delivery of health care
services via mobile communication devices]) is becoming a
significant part of the health care and health care economy.
Digital health funding has been steadily increasing. Tools for
developing and implementing mobile health care services and
research applications are becoming more and more available.
It is clear that the use of information and communication
technology can broaden rehabilitation and health care
research opportunities for researchers and service opportu-
nities for patients. In this session, the speakers provided three
levels of remote rehabilitation training management: full man-
agement (by health care professions), middle-level manage-
ment, and self-management (by patients). These different
levels are not mutually exclusive but are harmonious
approaches that allow the patient to transition from one
level of management to another, based on his/her progress
in recovery and changes in needs for care and services.
Many patients do not receive enough dose of rehabilitation
therapy after stroke. Telerehab is ideally suited to maximize the
gains from therapy; for instance, telerehab can increase the dura-
tion and intensity of therapy and therefore contribute to greater
functional gains. Pilot studies and clinical trials are ongoing
(Cramer) on a home-based telerehab system for patients with
stroke. Telerehab also offers the option for a holistic approach to
patient care, for example, incorporating education, sensor data
collection, and regular structured interactions with therapists.
Other technologies such as eHealth and mHealth can con-
tribute to health promotion emphasizing self-care rather than
expert care. In furthering the view that digital health technolo-
gies can help to overcome existing health care problems (e.g.,
lack of integration and coordination across different disciplines
and accessibility barriers), it was suggested that telerehab may
prevent well-known postrehabilitation health decline as the
patient transitions from dependence to independence.
Preliminary findings of the ongoing project (Rimmer), “TExT-
ME: Telehealth Exercise Training for Monitoring and
Evaluation of Home-Based Exercise,” show that home-based
tele-exercise interventions can achieve better participant adher-
ence than conventional onsite exercise programs, leading to
better health benefits. Participants of this tele-exercise program
reported that the convenience and online interaction with a
telecoach enhanced their motivation to attend the sessions.
This telecoaching (i.e., midmanagement) model may become a
precursor to self-management and mHealth for optimizing
recovery in people with neuromuscular disability.
On the other hand, the expansion of smartphone use and the
app design is literally placing sophisticated rehabilitation inter-
ventions in the hands of people with disabilities. Potential of
mRehab applications include symptom monitoring, real-time
data capture, real-time access to information about navigating
the community, social connectedness through peer to peer sup-
port, and bidirectional communication. However, there exist
barriers to use of mHealth, such as limited scientific evidence,
lack of integration of multiple perspectives and disciplines into
workflow, concerns over data confidentiality, privacy and secur-
ity, and lack of provisions for reimbursement. Of particular
concerns for the disability community is how factors at the
human-technology interface can impose barriers to use.
Accessibility and usability of mRehab interventions are essential
factors that must be considered throughout the app develop-
ment. An iterative interdisciplinary design process that brings
together content, accessibility, and information technology
experts with people with disabilities can help ensure the needs
and priorities of the disability community.
Many patients after acquiring a disability are unable to receive
the optimal amount of rehabilitation and health care services
because of a number of challenging barriers. With continuing
growth in the Internet and use of smartphones, the development
of digital health applications can significantly broaden rehabili-
tation and health care opportunities for patients. The full poten-
tial of digital health technologies to reach a large number of
people with disabilities who exhibit a range of physical and
psychosocial secondary health conditions and provide them
with effective dose of interventions has yet to be realized.
Transitions across the lifespan
(Moderator: Walter Frontera, MD, PhD, Vanderbilt University;
Panelists: Sharon Ramey, PhD, Virginia Polytechnic Institute
and State University; Ellen Giarelli, EdD, RN, MS, CRNP,
Drexel University; Eric Lenze, MD, Washington University)
116 W. R. FRONTERA ET AL.
D
ow
nl
oa
de
d 
by
 [1
08
.24
5.2
22
.13
1]
 at
 12
:04
 07
 Ja
nu
ary
 20
18
 
The purpose of this session was to examine current evidence
and discuss future research needs in the area of rehabilitation
across the lifespan with a particular emphasis on transitions.
Disability has an effect on growth and development, transitions
to adulthood, and aging (particularly disabling medical condi-
tions). At the same time, these processes can influence how
individuals adapt to the presence of disability and the nature of
their health care needs.
The first presentation focused on the need to increase the
number of implementation science trials to identify approaches
and strategies that work best with a high degree of certainty.
Examples of areas in need of this approach include studies on
cost/benefit ratio and health disparities. Rapid high-fidelity
science is needed to put research into practice more quickly. In
a real-world setting, it is important to know if the clinician is
familiar with the latest evidence and the best way to effectively
deliver care with high efficiency and consistency. We need to
understand the barriers and obstacles that prevent research
results from being implemented. In other words, why does it
take so much time and energy to change practice?
Health care, and specifically rehabilitation for patients with
chronic syndromes diagnosed in childhood, including those
associated with genetic variants, is best accomplished when it is
begun early in life, as soon as a diagnosis is pending, conceptua-
lized as requiring the integration of skills, knowledge, and clear
intentions of a diverse team, and the team is composed of the
patient, health care providers, family members, and other advo-
cates. Transitioning of any kind can be complicated and is always
highly personal. Furthermore, lifelong management is complex,
requires more health care, and is associated with higher costs.
Therefore, we must use models that capture sociocultural, envir-
onmental, and health variables and barriers to identify paths to
or loci of success. A fundamental goal is promoting the patient’s
skill at self-surveillance and self-management, including rehabi-
litation. There are no tricks, no magic, or fail safe; it is hard work
that must be individualized and supported.
Aging is associated with significant emotional, cognitive, and/
or motivational impairments that interfere with successful reha-
bilitation interventions. Clinical strategies that focus on patient
engagement and therapy intensity can help with behavioral
changes that are needed for successful rehabilitation. A model
of enhanced medical rehabilitation therapy was presented by
Dr. Lenze. This model includes a package of motivational and
high-intensity therapy steps that physical and occupational
therapists can take to maximize both patient engagement and
therapy intensity. Effort and progress are reinforced during
therapy with direct feedback to the patient and therapy is linked
to goals set by the patients. Older adults receiving therapy from
enhanced medical rehabilitation–trained therapists had greater
engagement in therapy sessions, higher patient active time, and
better functional recovery, compared with patients receiving
typical standard-of-care therapy.
Novel outcomes in rehabilitation and integration
into clinical care
(Moderator: Jonathan Bean, MD, Harvard Medical School;
Panelists: Brad Dicianno, MD, University of Pittsburgh;
Melissa Morrow, PhD, Mayo Clinic; Brian Hafner, PhD,
University of Washington)
The purpose of this session was to examine the clinical and
scientific relevance of developing novel outcomes in rehabili-
tation and its potential to favorably impact the changing
health care environment. Health care reform and the shifting
emphasis on managing health have been coupled with excep-
tional growth and development in the application of technol-
ogy and engineering to health measurement. As the mobile
health field and technologies evolve, researchers will continu-
ously be presented with challenges in the conceptual design
and deployment of clinical trials as well as the conduct of
clinical care owing to the vast array of outcomes measures
that can be collected.
The Interactive Mobile Health and Rehabilitation (iMHere)
system is an example of a mobile health system being used to
collect ecological momentary assessment outcomes data among
patients with spina bifida (Diciano). Furthermore, wearable
sensors monitoring different aspects of health are becoming
more widely used in rehabilitation research as a method of
capturing real-world outcomes. For example, sensor based out-
comes are being used (Morrow) in SCI rehabilitation research
although there are challenges to the integration of “big data” into
clinical practice. New approaches to outcomes measurement
have also been applied to the development of patient-reported
outcomes. National initiatives, like the Patient Reported
Outcomes Measurement Information System, have resulted in
rigorous frameworks for developing patient-reported outcomes
that can evaluate health outcomes across different patient popu-
lations. Efforts using these same methods to develop an item
bank specific to measuring prosthetic mobility in people with
lower limb loss were described.
The discussion following the presentations identified a number
of issues and challenges. These included a number of general
issues such as (1) the importance of developing a consolidated
infrastructure, be that through industry partnerships or academic
hubs; (2) using that infrastructure to develop systems that inte-
grate mHealth, wearables, and patient-reported outcomes in effi-
cient ways so that they complement each other to optimize
assessment and monitoring; (3) developing strategies to incorpo-
rate these integrated data elements into measurement systems
with which patients and clinicians can optimally engage and
interact; and (4) the integration of the resulting data into the
electronic medical record. Specific needs that were discussed
also included (1) developing “standards” or “best practices” for
wearable sensor technology akin to what the Patient Reported
Outcomes Measurement Information System had done for
patient-reported outcomes; (2) developing strategies for extracting
the “most important” data from wearable sensors and presenting
them in a way that is appropriate for the given stakeholder
(patients, practitioners, payers); and (3) using these approaches
for more optimal management of self-care and thus relieving
clinicians of the burden created by interpreting and processing
high volumes of data. Lastly, integrated leadership in addressing
these concerns was viewed as a priority for NIH, especially in
cooperation with other relevant agencies such as the Patient-
Centered Outcomes Research Institute, the Agency for
Healthcare Research and Quality, or the Veterans Health
Administration.
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Using data to drive discovery
(Moderator: Ken Ottenbacher, PhD, University of Texas
Medical Branch; Panelists: Adrian Hernandez, MD, Duke
University; James Graham, PhD, University of Texas
Medical Branch; Jennifer Hicks, PhD, Stanford University)
The purpose of this session was to examine the use of data
as a means to drive discovery. Using data to drive discovery
has been a hallmark of scientific investigation since the 1600s
beginning with the writings of Sir Francis Bacon regarding the
modern scientific method. How data have been defined and
used to generate new knowledge has evolved dramatically
since then. The pace has been particularly rapid during the
past decade. This revolution is being driven by several factors,
including (1) advances in information technology, (2) the
development of sophisticated data analytics, and (3) the
increased availability and complexity of data. These factors
provide opportunities for data integration, exploration, and
secondary analysis that did not exist even a few years ago. The
NIH “Big Data” program, referred to as BD2K (Big Data to
Knowledge) and launched in 2012, is a reflection of the data
revolution and its impact on biomedical and health care
sciences. For the fields of rehabilitation medicine and disabil-
ity sciences to fully participate in the research opportunities
associated with using data to drive discovery, there is a need
to raise awareness and build research capacity.
Significant opportunities exist for data exploration and
analyses in existing administrative and federal datasets,
including resources supported by the NIH specifically
designed for rehabilitation investigators, for example, Center
for Large Data Research & Data Sharing in Rehabilitation. In
addition, the Mobilize Center, an NIH BD2K Center of
Excellence, is using modern data science tools to integrate
and analyze information from wearable sensors, research
laboratories, and clinics to understand and improve human
mobility; for example, to improve treatment for patients with
CP. The NIH-funded National Center for Simulation in
Rehabilitation Research provides the worldwide rehabilitation
research community with a common platform for sharing
data and models that describe movement. Additional oppor-
tunities for discovery exist using large administrative or public
use databases such as Medicare claims and assessment files
and US Census data (including data related to the Affordable
Care Act and health care reform). There are rapidly emerging
opportunities for information sharing and secondary analyses
of data from completed studies associated with recent federal
data sharing and archiving mandates. The use of electronic
health records and the creation of large data networks and a
health system collaboratory represent yet another opportunity
to use clinical data with an emphasis on patient-reported and
patient-centered outcomes. Examples included the NIH
Collaboratory, the National Heart Lung and Blood Institute’s
Heart Failure Research Network, and the PCORnet: National
Patient-Centered Clinical Research Network, which includes
data from more than 100 million people.
Using data to drive discovery is an important and rapidly
expanding area of research with enormous potential to
advance rehabilitation science and patient care. This session
provided an introduction to the emerging discipline of Data
Science and its application and implications for rehabilitation
research. A better understanding of Data Science will help
rehabilitation clinicians, administrators and investigators
accomplish the Conference’s goal of “Moving the Field
Forward.”
Preventing secondary disability
(Moderator: Diane Damiano, PhD, PT, NIH Clinical Center;
Panelists: Greg Hicks, PhD, University of Delaware; Diann
Gaalema, PhD, University of Vermont; Sara Mulroy, PhD,
Rancho Los Amigos National Rehabilitation Center)
This session focused on major issues in prevention of
secondary disability across four distinct populations.
Children with CP, elderly adults with low back pain, adults
with SCIs, and adults recommended for cardiac rehabilitation
programs. Even with this diversity, many similarities were
seen across the presentations.
The scientific basis across populations for addressing sec-
ondary impairments focused on the identification of modifiable
factors that if addressed would improve outcomes in terms of
health and functioning for these individuals. For children with
CP, the focus was on physical activity throughout the lifespan
to preserve and maintain optimal muscle and brain function-
ing. A particular emphasis was the need to intervene very early
in life to limit the development of secondary changes due to the
inactivity imposed by the brain lesion. For elderly adults with
low back pain, trunk muscle integrity has been identified as a
key modifiable factor in this population that can reduce pain.
Interestingly, pain was previously thought to be an almost
inevitable part of normal aging, so much so that older adults
were typically excluded from studies on low back pain. The
patients at highest risk for poor outcomes after cardiac surgery
are often the ones who are least likely to attend rehabilitation
programs which have been shown to be efficacious in improv-
ing these outcomes. It is important to identify why these
individuals chose not to attend with the goal of devising stra-
tegies to improve their participation. Compliance with rehabi-
litation or with low term behavioral health changes was a
theme that resonated across speakers and the audience.
Efforts to incentivize patients to participate, while expensive,
may reduce health care costs tremendously if successful.
Another patient population with secondary disability is that
of individuals with SCIs with shoulder injuries. Using sophis-
ticated biomechanical analyses, movement patterns that mark-
edly diminished shoulder pain have been identified, again
showing that research is needed on modifiable factors that
enable people to remain or increase their ability to be mobile,
whether it is in a wheelchair or walking in the community. It
was emphasized that patients should have greater involvement
in our research so we can learn their concerns and challenges
and their individual factors that make them more likely to have
adverse health outcomes. In some instances, it can be socio-
economic status; in SCI in southern California, living in a
violent neighborhood increased the chances markedly of hav-
ing a SCI, both of which present very unique and specific
public health challenges in addition to the scientific challenges.
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Future recommendations for research are to better engage
our patients and their needs into our research efforts, to be
more open to alternative methodologies besides RCTs to find
cost-effective methods to help people maintain their health
across the lifespan. From a more translational science per-
spective, we need to know more about mechanisms leading to
pain across disorders and continue to explore biomechanical
and motor learning/training strategies to improve functional-
ity and reduce pain rather than masking the chronic pain with
medication. For children with CP, more effective early inter-
vention strategies need more investigation while at the same
time the intersection of aging with a disability is also a major
gap in the literature. Finally, secondary disability is hardly
secondary in cost, duration, and importance to patients.
However, because it occurs as a result of a primary injury,
these could theoretically all be avoidable or at least modifiable
and this is where rehabilitation research is needed.
Development of an NIH rehabilitation research plan
(Presenters: Dr. Alison Cernich and Dr. Lyn Jakeman)
The session covered the development of the new NIH
Rehabilitation Research Plan. The intent of the plan is to detail
research priorities that are of interest to a large group of the
Institutes and Centers in the NIH that invest in rehabilitation
research. A trans-NIH Medical Rehabilitation Research
Coordinating Committee began development of the plan in
2015. They developed the priorities in the plan in consultation
with the National Advisory Board on Medical Rehabilitation
Research and the directors of the NIH Institutes and Centers.
NIH published a draft of the plan asking for public comment in
November of 2015 and revised the plan based on that input.
Through feedback received through the request for public
input, the Medical Rehabilitation Research Coordinating
Committee modified the plan to include the development of
new methods to foster interdisciplinary research, placing
greater emphasis on health disparities, and broadening the
avenues for development of new technologies. As a result of
the comments, the Medical Rehabilitation Research
Coordinating Committee added two priority areas and revised
and refined other priority areas. The final plan includes six
priority areas: Rehabilitation Across the Lifespan, Family and
Community, Technology Use and Development, Translational
Science, Research Design and Methodology, and Research
Capacity and Infrastructure. The plan was intended to be
final in June and a town hall meeting at the conference
provided the final opportunity for feedback to the Medical
Rehabilitation Research Coordinating Committee before the
plan was published.
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